| Calisa Acquisition Corp Announces Entering into Merger Agreement with GoodVision AI Inc |
Globe Newswire |
03/09 |
07:30 |
| Bitcoin Bancorp to Present at NIBA’s 152nd Investment Conference in Fort Lauderdale Florida on March 11-12 |
Globe Newswire |
03/09 |
07:30 |
| SPARC AI Ready to Deploy Overwatch to Ukraine |
Globe Newswire |
03/09 |
07:30 |
| Korro Announces Oversubscribed $85 Million Private Placement |
Globe Newswire |
03/09 |
07:30 |
| SL Green Reaches 100% Leased at the Transformative One Madison Avenue, Projects Record-Breaking First Quarter Office Leasing Across Portfolio |
Globe Newswire |
03/09 |
07:30 |
| Nayax Reports Fourth Quarter and Full Year 2025 Results |
Globe Newswire |
03/09 |
07:30 |
| Green Circle Decarbonize Technology Limited Issues Statement Regarding Unusual Market Activity |
Globe Newswire |
03/09 |
07:30 |
| Movellus Advanced Clocking IP Selected for QuickLogic’s Strategic Radiation Hardened FPGA Program |
Globe Newswire |
03/09 |
07:11 |
| Dianthus Therapeutics Highlights Recent Business Achievements, Including GO Decision for Phase 3 CAPTIVATE CIDP Trial, and Reports Q4 and FY 2025 Financial Results |
Globe Newswire |
03/09 |
07:09 |
| Ubitium tapes out universal processor to end embedded computing complexity crisis |
Globe Newswire |
03/09 |
07:05 |
| Bitfarms Expands Leadership Team with Seasoned U.S. Industry Experts to Support HPC/AI Infrastructure Development |
Globe Newswire |
03/09 |
07:05 |
| Skyryse Announces Universal, Emergency Autoland Capability Coming to SkyOS™, Bringing Automated Safe Landings to Both Helicopters and Airplanes |
Globe Newswire |
03/09 |
07:05 |
| Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China |
Globe Newswire |
03/09 |
07:00 |
| Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update |
Globe Newswire |
03/09 |
07:00 |
| Nasdaq to launch equity token design, putting issuers at the center of tokenization |
Globe Newswire |
03/09 |
07:00 |
| 3D Systems Reports Fourth Quarter and Full Year 2025 Financial Results |
Globe Newswire |
03/09 |
07:00 |
| Siris Agrees to Acquire a Majority Stake in TAKKION from Apollo Funds |
Globe Newswire |
03/09 |
07:00 |
| Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights |
Globe Newswire |
03/09 |
07:00 |
| Dianthus Therapeutics Announces Early GO Decision Following Interim Responder Analysis in Phase 3 CAPTIVATE Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
Globe Newswire |
03/09 |
07:00 |
| Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference |
Globe Newswire |
03/09 |
07:00 |
| NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study |
Globe Newswire |
03/09 |
07:00 |
| B2BROKER and Centroid Strengthen Collaboration to Enhance B2TRADER Liquidity and Risk Capabilities |
Globe Newswire |
03/09 |
07:00 |
| Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS) |
Globe Newswire |
03/09 |
07:00 |
| Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients |
Globe Newswire |
03/09 |
07:00 |
| DecisionDx®-Melanoma’s i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Than 5% Risk |
Globe Newswire |
03/09 |
07:00 |
